They raised $2.75MWonder if that'll last through Q1 at least, with whatever money they already had in the kitty. Best case, the results and FDA submission allow them to cast a wider net for funding. Heck, maybe even try to sell a million shares via NASDAQ at two bucks a pop. 'Nuff of that. Anyone check the MD&A for finances?